This trial is terminated!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
2Find
3Review
4Get in touch
More info
You can access this
clinical trial
if you have
Acute Lymphoblastic Leukemia (ALL)
and you are
over 60
years old
3
This is a trial in the final phase before the treatment is released on the market.
Show me locations

The purpose

A phase 3 study in the treatment of subjects >or= 60 years old with newly diagnosed acute lymphoblastic leukemia (ALL).

Provided treatments

  • Drug: Vincristine Sulfate Liposomes Injection (VSLI)
  • Drug: Vincristine Sulfate Injection (VSI)

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT01439347. The sponsor of the trial is Spectrum Pharmaceuticals, Inc and it is looking for 26 volunteers for the current phase.
Official trial title:
Phase 3 Study of Study to Evaluate Marqibo® in the Combination Chemotherapy in the Treatment of Subjects >or=60 Years Old With Newly Diagnosed Acute Lymphoblastic Leukemia (ALL)